JENNIFER DANIEL: Open Payments
NPI 1669875241 · DANVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,895 in 98 payments from 22 companies in 2025. Trend: 2023 $1,518 · 2024 $1,565 · 2025 $1,895
Food & beverage: $1,760Education: $135
| Company | Payments | Amount |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | 18 | $258 |
| Madrigal Pharmaceuticals | 10 | $251 |
| HARMONY BIOSCIENCES LLC | 13 | $237 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $188 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $157 |
| Verona Pharma, Inc. | 7 | $140 |
| QOL Medical, LLC | 5 | $128 |
| Phathom Pharmaceuticals, Inc. | 3 | $106 |
| Regeneron Healthcare Solutions, Inc. | 3 | $72 |
| Janssen Biotech, Inc. | 3 | $58 |
Products named: REZDIFFRA, WAKIX, ENTYVIO, XIFAXAN, Ohtuvayre, Sucraid, VOQUEZNA, DUPIXENT.
Industry payments across KY — which companies pay providers there.
